Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt Pathway.

Authors:
Wang L; Xu L; Han S; Zhu X.

Journal:
Can Respir J

Publication Year: 2024

DOI:
10.1155/2024/2632014

PMCID:
PMC10927342

PMID:
38468814

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Can Respir J

Abbreviation: Can Respir J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Clustered Cystic Changes in Long-Term Follow-Up Thin-Section Computed Tomographic Findings in Fibro…
Akira M; Suganuma N. (2024) - Transparency Score: 2/6
Hypersensitivity Pneumonitis: Challenges of a Complex Disease.
Calaras D; David A; Vasarmidi E and 2 more (2024) - Transparency Score: 2/6
A Novel Scale to Assess Humidification during Noninvasive Ventilation: A Prospective Observational …
Pan L; Hong Y; Zhong X and 6 more (2023) - Transparency Score: 2/6
Blood Eosinophil Count as a Predictive Biomarker of Chronic Obstructive Pulmonary Disease Exacerbat…
Komura M; Sato T; Suzuki Y and 10 more (2023) - Transparency Score: 2/6
Construction and Validation of a Predictive Model for the Risk of Ventilator-Associated Pneumonia i…
Li S; Shang L; Yuan L and 5 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that they have no conflicts of interest."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025